ACMR(ACMR)
ACMR
Q4 2026 EPS Estimate
$0.49
Nov 11, 2026 · Reports before open
Revenue Estimate
$311M
FY2026E EPS$2.00
FY2027E EPS$2.86
Analyst Sentiment
Wall St. Consensus
Buy10 analysts·Moderate coverage
70
Score
8 Buy (80%)2 Hold (20%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
880%
Hold
220%
Sell
00%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$75.00
-5.6%
Consensus
$112.50
+41.7%
Bull
$130.00
+63.7%
12-Month Target Range10 analysts
$75.00$112.50$130.00
Current $79.41Consensus
Current Price
$79.41
Upside to Consensus
$33.09
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+24.45%
EPS+43.20%
FY2028
Rev+32.17%
EPS+53.85%
FY2029
Rev+15.06%
EPS-4.32%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $1.15B | $1.44B | $1.90B | $2.19B | $2.55B |
| Low | $1.14B | $1.33B | $1.82B | $2.06B | $2.40B |
| High | $1.17B | $1.52B | $2.02B | $2.38B | $2.77B |
| EBITDA Avg | $224M | $279M | $369M | $424M | $495M |
| Low | $222M | $258M | $355M | $400M | $466M |
| High | $228M | $294M | $393M | $462M | $538M |
| EBIT Avg | $194M | $241M | $319M | $367M | $427M |
| Low | $192M | $223M | $306M | $345M | $403M |
| High | $197M | $254M | $339M | $399M | $465M |
| Net Income Avg | $137M | $196M | $273M | $283M | $345M |
| Low | $124M | $178M | $230M | $262M | $319M |
| High | $150M | $215M | $386M | $316M | $384M |
| EPS Avg | $2.00 | $2.86 | $4.40 | $4.21 | $5.12 |
| Low | $1.85 | $2.64 | $3.41 | $3.89 | $4.73 |
| High | $2.23 | $3.19 | $5.74 | $4.69 | $5.71 |
| Analysts (Rev / EPS) | 5 / 3 | 5 / 3 | 3 / 3 | 1 / 1 | 2 / 1 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $322M | $335M | $284M | $322M | $359M | $372M |
| Low | $300M | $310M | $263M | $297M | $332M | $344M |
| High | $342M | $358M | $304M | $343M | $384M | $397M |
| EBITDA Avg | $63M | $65M | $55M | $62M | $70M | $72M |
| Low | $58M | $60M | $51M | $58M | $65M | $67M |
| High | $66M | $69M | $59M | $67M | $75M | $77M |
| EBIT Avg | $54M | $56M | $48M | $54M | $60M | $62M |
| Low | $50M | $52M | $44M | $50M | $56M | $58M |
| High | $57M | $60M | $51M | $58M | $64M | $67M |
| Net Income Avg | $41M | $46M | $37M | $43M | $55M | $62M |
| Low | $37M | $41M | $33M | $39M | $49M | $56M |
| High | $44M | $50M | $40M | $47M | $60M | $68M |
| EPS Avg | $0.57 | $0.65 | $0.53 | $0.61 | $0.78 | $0.88 |
| Low | $0.52 | $0.58 | $0.47 | $0.55 | $0.70 | $0.79 |
| High | $0.63 | $0.70 | $0.57 | $0.66 | $0.84 | $0.96 |
| Analysts (Rev / EPS) | 5 / 2 | 4 / 1 | 4 / 1 | 4 / 1 | 4 / 1 | 4 / 1 |